Amphetamine Addiction Clinical Trial
Official title:
Development of Virtual Reality-Based Addiction Assessment System for Synthetic Drugs Addiction
The purpose of this research is to develop an objective assessment based on the virtual reality techniques which is used for evaluate addiction severity.
In order to evaluate the addiction severity and the effect of rehabilitation objectively, this study develops a virtual environment model based on the virtual reality technique, making the subjects in a drug related or neutral scene , at the same time recording the physical signs and eye movements index. Reliability and validity of this system will also be tested in this study. And we will construct the norm of addiction assessment system in Shanghai .The evaluating system will be very beneficial to develop novel and practical assessment for synthetic durg related disorder, and provide a reference for other drug dependence diagnosis. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05535101 -
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
|
N/A | |
Not yet recruiting |
NCT02836756 -
Cannabidiol as a New Intervention for Amphetamine Dependence
|
Phase 2 | |
Completed |
NCT03318081 -
The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction
|
N/A | |
Completed |
NCT03221283 -
The Application of Music Therapy in Female Amphetamine Use Disorder
|
N/A | |
Withdrawn |
NCT02952196 -
Cannabioids as a New Intervention for Amphetamine Dependence
|
Phase 2 | |
Completed |
NCT02285556 -
The Diagnostic Assessment and Intervention Study of Amphetamine Type Stimulus
|
N/A | |
Completed |
NCT02713815 -
Novel Intervention for Amphetamine-type Stimulants Addiction
|
N/A | |
Completed |
NCT00713479 -
An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
|
Phase 1 | |
Completed |
NCT04993300 -
Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction
|
N/A | |
Recruiting |
NCT04531384 -
Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.
|
N/A | |
Recruiting |
NCT04687566 -
Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction
|
Phase 2/Phase 3 |